Skip to content

Postoperative bowel dysfunction: effect of less opioid anesthesia and enhanced recovery after complex spine surgery: prospective randomized controlled trial

Postoperative bowel dysfunction: effect of less opioid anesthesia and enhanced recovery after complex spine surgery: prospective randomized controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20201229001
Enrollment
Unknown
Registered
2020-12-29
Start date
2021-11-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elective complex spine surgery postoperative bowel dysfunction, postoperative ileus, Enhanced Recovery After Surgery, spine surgery, intraoperative opioid

Interventions

fentanyl 1&#45
2 mcg/kg then fentanyl 0.5&#45
1 mg/kg as need volatile anesthesia 0.5&#45
1.5 MAC,volatile anesthesia 0.5 MAC TCI propofol Cet 2&#45
6 mcg/ml lidocain 1.5&#45
2 mg/kg IV magnesium sulfate 40 mg/kg IV ketamine 0.3 .g/kg IV nefopam 20 mg IV then 60 mg in 24 hour postoperatively
Active Comparator Drug,Experimental Drug
opioid group,less opioid group

Sponsors

faculty of medicine siriaj hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ASA class 1-3 Elective surgery thoracic or lumbar complex spine surgery (spinal instrument or more than 3 level )

Exclusion criteria

Exclusion criteria: patient refusal Cr > 2 mg/dL , eGFR < 50ml/min patient with caronary artery disease, congestive heart failure pateint with cerebrovascular disease, seizure BMI > 30 kg/m2. or body weight < 50 kg patient with spinal cord injury (complete cord lesion) patient with spinal tumor intraoperative neuromonitorings uncontrolled hypertension (BP > 180/110) constipation (defecation 2days/time) or use of laxatives patient with irritable bowel syndrome previous abdominal surgery patient recieved calcium channel blocker allergy to gabapentin, ketamine, magnesium, dexamethasone, lidocaine, dexamathesone, parecoxib, morphine,fentanyl disable to use intravenous patient controlled analgesia communication problem preoperative unstable hemodynamics

Design outcomes

Primary

MeasureTime frame
incidence of postopeartive bowel dysfunction 12 months first postoperative defecation before 48 hours

Secondary

MeasureTime frame
incidences of nausea vomiting, 12 months incidence,incidences of abdominal distention 12 months incidence,incidences of fart before 48 hours 12 months incidence,dietary habit 12 months subjective measurement

Countries

Thailand

Contacts

Public ContactThanitthi Thiparporn

siriraj hospital

thanitthi0111@gmail.com0815490323

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026